Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PHARMASSET INC Analyst Recommendations

  • Analyst Consensus: VRUS

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.538 Buy 13
    30 Days Ago 1.583 Buy 12
    60 Days Ago 1.636 Buy 11
    90 Days Ago 1.818 Buy 11
    120 Days Ago 1.917 Buy 12

  • Analyst Ratings: VRUS

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Wedbush Morgan — Outperform 10/21/2009 34.00
    UBS — Neutral 10/07/2009 23.00
    ThinkEquity — Buy 09/08/2009 29.00
    Robert W. Baird Neutral Outperform 09/07/2009 30.00
    UBS — Buy 04/21/2009 10.00
    Wedbush Morgan — Buy 03/18/2009 18.00
    Roth Capital Sell Hold 03/03/2009 —
    JMP Securities — Mkt Perform 02/17/2009 20.00
    ThinkEquity — Buy 01/27/2009 20.00
    JMP Securities — Mkt Outperform 12/15/2008 25.00
    Roth Capital — Sell 12/05/2008 —
    Merriman Curhan Ford — Buy 10/30/2008 —
    Cowen & Co — Outperform 10/29/2008 —
    Lazard Capital — Buy 10/21/2008 27.00
    Leerink Swann — Outperform 07/28/2008 —
    Pacific Growth Equities — Buy 05/21/2008 —
    Robert W. Baird — Neutral 04/16/2008 21.00
    UBS Neutral Buy 04/02/2008 —
    Merriman Curhan Ford — Buy 03/11/2008 —
    UBS Buy Neutral 02/19/2008 —
    JMP Securities — Mkt Outperform 01/29/2008 —
    Stifel Nicolaus Buy Hold 01/08/2008 —
    Susquehanna Financial — Positive 12/07/2007 —
    UBS — Buy 11/07/2007 17.00
    Canaccord Adams — Buy 11/07/2007 —
    UBS — Buy 06/11/2007 —
    Stifel Nicolaus — Buy 06/08/2007 13.00
    JMP Securities — Mkt Outperform 06/07/2007 14.00
    Banc of America Sec — Buy 06/06/2007 12.00